Development of a novel predictive nomogram to prevent ‘futile surgery’ in gallbladder cancers: A single center analysis of 1196 resected gallbladder cancers
European Journal of Surgical Oncology · 2025
DOI: 10.1016/j.ejso.2025.110492 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Surgical Oncology, 2025. Verfasst von Gurudutt P Varty und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal and Hepato-pancreato-biliary Surgery, Department of Surgical Oncology, Tata Memorial Hospital, Homi Bhabha National In…. Hauptthemen laut MEDLINE: Gallbladder Neoplasms, Nomograms, Adenocarcinoma, Cholecystectomy. Die Arbeit nennt 38 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: Advancement in technical expertise, perioperative care and chemotherapeutic regimes have led to stretching the limits of surgery for gallbladder cancers (GBCs). Being an inherently aggressive cancer, do all the patients of GBCs really benefit from a surgical procedure? METHODS: A total of 1196 cases of gallbladder adenocarcinoma who underwent curative resection from January 2010 to December 2023 were analysed. FS was defined as recurrences or deaths within 6 months of surgery. A multivariate model was built and a preoperative nomogram was created. RESULTS: A total of 133 (11.1 %) patients underwent a FS with a median overall survival of 8.9 months compared to 88.7 months for patients who underwent a non-futile surgery (p < 0.001). Predefined 'TMH criteria' was used to differentiate 'borderline resectable' GBC (BR-GBC, n = 344, 28.8 %) from upfront resectable GBC (n = 852, 71.2 %) and were subjected to neoadjuvant chemotherapy. Multivariable analysis revealed log CA 19-9 (OR - 1.12, 95 %CI - 1.02-1.22, p = 0.014), borderline resectable GBCs (OR, 1.97, 95 %CI, 1.34-2.88, p = 0.001) and extended/multivisceral resection (OR - 2.01, 95 %CI - 1.13-3.45, p = 0.014) as key preoperative factors predicting a FS. A predictive nomogram was built based on these preoperative factors which had a classification accuracy of 0.888 and a precision of 0.790 on internal validation. CONCLUSION: In modern day oncology where tumour biology and patient selection assumes prime importance, incorporating our predictive nomogram in preoperative clinical decision-making pathway may guide the clinicians to avoid FS in patients of GBC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Gastrointestinal and Hepato-pancreato-biliary Surgery, Department of Surgical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, Maharashtra, India. Electronic address: gurudutt89@gm…
- Department of Gastrointestinal and Hepato-pancreato-biliary Surgery, Department of Surgical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, Maharashtra, India. Electronic address: drshraddhapat…
- Department of Colorectal Surgical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, Maharashtra, India. Electronic address: mufaddalkazi@live.com.
- Department of Surgical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, Maharashtra, India. Electronic address: karthikvelmurugan27@gmail.com.
- Department of Surgical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, Maharashtra, India. Electronic address: amitasekharpadhy@gmail.com.
- Department of Surgical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, Maharashtra, India. Electronic address: baskarand1001@gmail.com.
Zitieren
APA
Varty, G. P., Patkar, S., Kazi, M., Velmurugan, K., Padhy, A. S., Dhanapal, B., Lele, S., Kamini, S., Kaderi, A. S. A., Pawar, A., Yadav, S., Gudi, S., Gala, K. B., Bhargava, P., Ramaswamy, A., Ostwal, V., & Goel, M. (2025). Development of a novel predictive nomogram to prevent ‘futile surgery’ in gallbladder cancers: A single center analysis of 1196 resected gallbladder cancers. European Journal of Surgical Oncology. https://doi.org/10.1016/j.ejso.2025.110492
Vancouver
Varty GP, Patkar S, Kazi M, Velmurugan K, Padhy AS, Dhanapal B, et al. Development of a novel predictive nomogram to prevent ‘futile surgery’ in gallbladder cancers: A single center analysis of 1196 resected gallbladder cancers. European Journal of Surgical Oncology. 2025. doi:10.1016/j.ejso.2025.110492
BibTeX
@article{Varty2025,
author = {Varty, Gurudutt P and Patkar, Shraddha and Kazi, Mufaddal and Velmurugan, Karthik and Padhy, Amita Sekhar and Dhanapal, Baskaran and Lele, Sujat and Kamini, Snigdha and Kaderi, Abdeali Saif Arif and Pawar, Akash and Yadav, Subhash and Gudi, Shivakumar and Gala, Kunal B and Bhargava, Prabhat and Ramaswamy, Anant and Ostwal, Vikas and Goel, Mahesh},
title = {Development of a novel predictive nomogram to prevent ‘futile surgery’ in gallbladder cancers: A single center analysis of 1196 resected gallbladder cancers},
journal = {European Journal of Surgical Oncology},
year = {2025},
doi = {10.1016/j.ejso.2025.110492}
}
EUVIMED